7Zamchetti A. Antiatherosclerotic effects of antihypertensive drugs: recent evidence and ougoing trials [ J ]. Clip Exp Hyperten,1996,18:489-499.
8PittB, Byington RP, Furberh CD, et al. Effect of amlodipine on the Profressin of atherosclerosis and the occurrence of clinical erents PREVENT Investigators [ J ]. Circulation, 2002,102: 1503-151.
9Nissen SE.High-close statins in acute coronary syndromes Not just lipid lerels[J].JAMA,2004;1292:1365-1367.
61Hamllet JD,Foley RN,Kent GM. Congestive heart failure in dialysis patient prevalence,incidence,prognosis and risk factors[J].{H}Kidney International,1995,(04):884-891.
7Go AS,Chertow GM,Fan D. Chronic kidney disease and the risks of death,cardiovascular events,and hosiptalization[J].New England Journal ofMedicine,2004,(13):1296-1305.
8Sarnak MJ. Cardiovascular complications in chronic kidney disease[J].AmJKidneyDis,2003,(6suppl5):S11-S17.
9Tramontano AF,Muniyappa R,Black AD. Erythropoietin protects cardiac myocytes from hypoxia-induced apoptosis through an Akt-dependent pathway[J].{H}Biochemical and Biophysical Research Communications,2003,(04):990-994.
10Massy ZA,Ceballos I,Chadefaux-Vekemens B. Homocysteine,oxidative stress,and endothelium function in uremic patients[J].{H}Kidney International,2001.S243-S245.
